2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Correlation Between Grace Risk Score and Cardiovascular Event Rate in Patients With St Segment Elevation Myocardial Infarction With Successful Fibrinolysis and Delayed Coronary Intervention

“…Also, The NORwegian study onDistrict treatment of ST-Elevation Myocardial infarction (NORDISTEMI) study also demonstrated a significant reduction in the composite cardiovascular outcome (death, re-infarction, stroke, or recurrent ischemia) at 1 year in the patients with immediate transferred to PCI following with thrombolysis as compared with the patients in conservative arm treatment (6 % vs 16 %, p = 0.01) [7].…”

“…triglyceride ≥ 150 mg/dl, high-density lipoprotein (HDL cholesterol) ≤ 40 mg/dl or current use of antihyperlipdemic drug [7], hypertension was defined as systolic/diastolic blood pressure ≥ 140/90 mmHg or patients having history of hypertension and current use of any antihypertensive medications [8], Family history of premature coronary artery disease was defined as fatal or non-fatal events in first degree relatives men<55 or women <60 years [9].…”

Comparative Study of Predictive Value for Different Risk Scores for Predicting Contrast Induced Nephropathy and Short Outcome after Primary Percutaneous Coronary Intervention

“…History was taken including age, gender, smoking was recognized as a lifetime history of >100 cigarettes in their entire life and had continued smoking in the last 6 months was considered a positive smoking history) 17while ex-smokers were defined having history of smoking at least 100 cigarettes in their entire life and had completely stopped smoking for at least 6 months) [17], Current diabetes mellitus was recognized as having history of DM on admission with the use of oral anti-hyperglycemic full agents or any extended release insulin and confirmed by laboratory HbA1c on admission if more than 6.5% [18], dyslipidemia was defined by total cholesterol ≥ 220 mg/dl, triglyceride ≥ 150 mg/dl, high-density lipoprotein (HDL cholesterol) ≥ 40 mg/dl or current use of anti-hyperlipdemic drug [19][20][21], hypertension was defined as systolic/diastolic blood pressure ≥ 140/90 mmHg or patients having history of hypertension and current use of any antihypertensive medications [22], Family history of premature coronary artery disease was defined as fatal or non-fatal events in first degree relatives men<55 or women <60 years [19], previous PCI procedures and previous CABG, other co-morbid conditions such as previous cerebrovascular stroke, renal impairment and the presence of peripheral vascular disease.…”

Clinician — Treats, and Patient — Being Treated? Recent View on the Treatment Adherence in Coronary Heart Disease Setting

“…Выделено также понятие "конкордантность" (concordance). Она определяется как согласованная между пациентом и врачом позиция относительно режима лечения, результатов и соответствующего поведения; отношения в большей степени совмест-ные, чем определяемые комплайнсом [2]. Pardaens S, et al (2017) изучали причины выхода пациентов из программ кардиореабилитации после ОКС, кардиохирургического вмешательства и при сердечной недостаточности.…”

“…Выделено также понятие "конкордантность" (concordance). Она определяется как согласованная между пациентом и врачом позиция относительно режима лечения, результатов и соответствующего поведения; отношения в большей степени совмест-ные, чем определяемые комплайнсом [2].…”